The companies we have invested in.

CLD-9 uses robotics to make personalized medicine scalable, precision formulation built to serve tens of thousands of people a month as it scales.

Agencity's role: Early investor, in before Antler and Boost VC. Operating partner for go-to-market across India, the US, and the Gulf, including representing the company to investors and partners in Abu Dhabi.

Biomimetic, mussel-inspired polymer chemistry that bonds and coats on wet and submerged surfaces, where conventional adhesives fail. Applications span defense (US Navy contracts), dental, biomedical, and industrial repair. The company is closing a $10M Series A.

Agencity's role: Series A investor, and operating partner for the company's India expansion through a major Indian real-estate and construction group.

The fundraising platform for founders: identifies the investors most likely to fund a round using live behavioral signals, automates outreach personalized to each investor's thesis, and manages the raise through to close.

Agencity's role: Investor (July 2026).

Nuron builds world models: AI systems that learn a compact internal representation of the world from video and predict how it evolves. The lab is in stealth, and that is deliberate.

Agencity's role: Founding partner.